ImmunityBio, Inc.IBRXNASDAQ
Loading
ROIC: Strong ReturnsExpanding
Percentile Rank58
Studio
Year-over-Year Change

Return on invested capital

Latest
-56.95%
↑ 26% vs avg
Percentile
P58
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
-77.46%
Historical baseline
PeriodValueYoY Change
2025-56.95%+44.5%
2024-102.60%-27.9%
2023-80.24%+32.4%
2022-118.66%-44.5%
2021-82.13%+40.7%
2020-138.43%-180.8%
2019-49.30%+21.6%
2018-62.88%-46.8%
2017-42.84%-5.6%
2016-40.56%-